Display options
Share it on

Appl Clin Genet. 2015 Oct 30;8:245-55. doi: 10.2147/TACG.S68650. eCollection 2015.

Diagnostic and treatment strategies in mucopolysaccharidosis VI.

The application of clinical genetics

Filippo Vairo, Andressa Federhen, Guilherme Baldo, Mariluce Riegel, Maira Burin, Sandra Leistner-Segal, Roberto Giugliani

Affiliations

  1. Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil ; Clinical Research Group on Medical Genetics, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  2. Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Clinical Research Group on Medical Genetics, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Post-Graduate Program in Child and Adolescent Health, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  3. Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil ; Gene Therapy Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil ; Department of Physiology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  4. Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  5. Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  6. Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Post-Graduate Program in Medical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  7. Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil ; Clinical Research Group on Medical Genetics, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Post-Graduate Program in Child and Adolescent Health, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil ; Gene Therapy Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil ; Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil ; Post-Graduate Program in Medical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

PMID: 26586959 PMCID: PMC4634832 DOI: 10.2147/TACG.S68650

Abstract

Mucopolysaccharidosis VI (MPS VI) is a very rare autosomal recessive disorder caused by mutations in the ARSB gene, which lead to deficient activity of the lysosomal enzyme ASB. This enzyme is important for the breakdown of the glycosaminoglycans (GAGs) dermatan sulfate and chondroitin sulfate, which accumulate in body tissues and organs of MPS VI patients. The storage of GAGs (especially dermatan sulfate) causes bone dysplasia, joint restriction, organomegaly, heart disease, and corneal clouding, among several other problems, and reduced life span. Despite the fact that most cases are severe, there is a spectrum of severity and some cases are so attenuated that diagnosis is made late in life. Although the analysis of urinary GAGs and/or the measurement of enzyme activity in dried blood spots are useful screening methods, the diagnosis is based in the demonstration of the enzyme deficiency in leucocytes or fibroblasts, and/or in the identification of pathogenic mutations in the ARSB gene. Specific treatment with enzyme replacement has been available since 2005. It is safe and effective, bringing measurable benefits and increased survival to patients. As several evidences indicate that early initiation of therapy may lead to a better outcome, newborn screening is being considered for this condition, and it is already in place in selected areas where the incidence of MPS VI is increased. However, as enzyme replacement therapy is not curative, associated therapies should be considered, and research on innovative therapies continues. The management of affected patients by a multidisciplinary team with experience in MPS diseases is highly recommended.

Keywords: Maroteaux–Lamy syndrome; arylsulfatase b; dermatan sulfate; enzyme replacement therapy; lysosomal storage diseases; mucopolysaccharidosis VI

References

  1. J Genet Couns. 2013 Dec;22(6):830-4 - PubMed
  2. Pediatrics. 2005 Jun;115(6):e681-9 - PubMed
  3. Genet Med. 2009 Apr;11(4):232-40 - PubMed
  4. Int Ophthalmol. 2009 Aug;29(4):267-9 - PubMed
  5. Orphanet J Rare Dis. 2010 Apr 12;5:5 - PubMed
  6. Hum Mutat. 2007 Sep;28(9):897-903 - PubMed
  7. Tunis Med. 2009 Nov;87(11):782-5 - PubMed
  8. Hum Gene Ther Clin Dev. 2015 Mar;26(1):27-37 - PubMed
  9. Biol Chem Hoppe Seyler. 1993 May;374(5):327-35 - PubMed
  10. Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):222-7 - PubMed
  11. Biochim Biophys Acta. 1999 Feb 24;1453(2):185-92 - PubMed
  12. Mol Genet Metab. 2010 Feb;99(2):132-41 - PubMed
  13. Ann Allergy Asthma Immunol. 2013 Jan;110(1):55-6 - PubMed
  14. J Biol Chem. 1991 Nov 15;266(32):21386-91 - PubMed
  15. J Inherit Metab Dis. 2012 Nov;35(6):1071-9 - PubMed
  16. Mol Ther. 2012 May;20(5):898-907 - PubMed
  17. Hum Exp Toxicol. 2011 Jul;30(7):768-71 - PubMed
  18. Rheum Dis Clin North Am. 2013 May;39(2):431-55 - PubMed
  19. Mol Genet Metab. 2011 Nov;104(3):295-300 - PubMed
  20. Mol Genet Metab. 2010 Apr;99(4):346-50 - PubMed
  21. Hum Mutat. 2001 Oct;18(4):282-95 - PubMed
  22. Biotechnol Appl Biochem. 2008 Mar;49(Pt 3):219-23 - PubMed
  23. Mol Genet Metab. 2013 May;109(1):62-9 - PubMed
  24. J Appl Genet. 2015 May;56(2):205-10 - PubMed
  25. Curr Opin Hematol. 1999 Nov;6(6):377-82 - PubMed
  26. Clin Genet. 2010 May;77(5):492-8 - PubMed
  27. Presse Med. 1963 Sep 25;71:1849-52 - PubMed
  28. Clin Chim Acta. 2013 Jan 16;415:334-6 - PubMed
  29. Mol Genet Metab. 2014 Feb;111(2):63-72 - PubMed
  30. Am J Med Genet A. 2003 Dec 15;123A(3):310-3 - PubMed
  31. Eur J Hum Genet. 2004 Feb;12(2):87-92 - PubMed
  32. Pediatrics. 2007 Aug;120(2):405-18 - PubMed
  33. Acta Paediatr. 2008 Nov;97(11):1577-81 - PubMed
  34. J Inherit Metab Dis. 2014 Mar;37(2):277-87 - PubMed
  35. J Inherit Metab Dis. 2013 Nov;36(6):1005-13 - PubMed
  36. Br J Radiol. 1982 Nov;55(659):805-12 - PubMed
  37. Mol Genet Metab. 2011 Dec;104(4):603-7 - PubMed
  38. J Pediatr (Rio J). 2008 Mar-Apr;84(2):130-5 - PubMed
  39. Hum Genet. 1999 Jul-Aug;105(1-2):151-6 - PubMed
  40. Mol Genet Metab. 2012 Sep;107(1-2):15-24 - PubMed
  41. Mol Genet Metab. 2011 Jan;102(1):49-56 - PubMed
  42. J Biol Chem. 1990 Feb 25;265(6):3374-81 - PubMed
  43. Genet Test Mol Biomarkers. 2012 Aug;16(8):846-9 - PubMed
  44. Genetika. 2000 Jun;36(6):837-43 - PubMed
  45. Mol Genet Metab. 2012 May;106(1):73-82 - PubMed
  46. Ann Neurol. 1979 Oct;6(4):315-25 - PubMed
  47. World J Pediatr. 2008 May;4(2):152-4 - PubMed
  48. Pediatr Int. 2006 Oct;48(5):498-500 - PubMed
  49. J Pediatr. 2006 Apr;148(4):533-539 - PubMed
  50. Mol Genet Metab. 1999 Jul;67(3):194-205 - PubMed
  51. J Inherit Metab Dis. 2005;28(6):1011-7 - PubMed
  52. PLoS One. 2013;8(1):e54459 - PubMed
  53. Ann Saudi Med. 2010 Jul-Aug;30(4):271-7 - PubMed
  54. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 - PubMed
  55. Am J Med Genet A. 2006 Aug 1;140(15):1684-6 - PubMed
  56. Clin Chem. 1992 Jun;38(6):803-7 - PubMed
  57. Am J Med Genet A. 2005 Apr 15;134A(2):144-50 - PubMed
  58. Am J Med Genet A. 2014 Aug;164A(8):1953-64 - PubMed
  59. Pediatr Int. 2014 Aug;56(4):520-5 - PubMed
  60. JAMA. 1999 Jan 20;281(3):249-54 - PubMed
  61. Am J Med Genet A. 2009 May;149A(5):960-4 - PubMed
  62. Springer Semin Immunopathol. 2004 Nov;26(1-2):119-32 - PubMed
  63. Clin Chem. 2008 Jul;54(7):1141-8 - PubMed
  64. Clin Genet. 2004 Sep;66(3):208-13 - PubMed
  65. J Pediatr Rehabil Med. 2010;3(2):89-100 - PubMed
  66. J Clin Invest. 1993 Mar;91(3):1099-104 - PubMed
  67. Hum Hered. 2014;77(1-4):189-96 - PubMed
  68. Mol Genet Metab. 2012 Feb;105(2):237-43 - PubMed
  69. Eur J Pediatr. 1997 Aug;156(8):650-4 - PubMed
  70. Biochim Biophys Acta. 1998 Apr 28;1406(3):283-90 - PubMed
  71. Am J Med Genet A. 2012 May;158A(5):1055-9 - PubMed
  72. J Inherit Metab Dis. 2005;28(6):1027-34 - PubMed
  73. Mol Genet Metab. 2005 Jul;85(3):236-8 - PubMed
  74. Mol Genet Metab. 2003 Mar;78(3):163-74 - PubMed
  75. J Formos Med Assoc. 2001 Dec;100(12):820-3 - PubMed
  76. J Biol Chem. 1999 Dec 17;274(51):36335-43 - PubMed
  77. PLoS One. 2011;6(8):e22447 - PubMed
  78. J Inherit Metab Dis. 2013 Mar;36(2):373-84 - PubMed
  79. J Inherit Metab Dis. 2010 Aug;33(4):387-96 - PubMed
  80. Case Rep Ophthalmol. 2012 Jan;3(1):104-12 - PubMed
  81. Mol Genet Metab. 2008 Aug;94(4):469-75 - PubMed
  82. Turk J Pediatr. 2010 Sep-Oct;52(5):443-9 - PubMed
  83. Am J Hum Genet. 1994 Mar;54(3):454-63 - PubMed
  84. Clin Chem. 1989 Oct;35(10):2074-81 - PubMed
  85. Am J Hum Genet. 1996 Jun;58(6):1127-34 - PubMed
  86. Curr Pharm Biotechnol. 2011 Jun;12(6):956-62 - PubMed
  87. Biochim Biophys Acta. 1999 Feb 24;1453(2):284-96 - PubMed
  88. J Inherit Metab Dis. 1999 Feb;22(1):50-62 - PubMed
  89. Hum Gene Ther. 2013 Feb;24(2):163-9 - PubMed
  90. Clin Chem. 2015 Feb;61(2):335-46 - PubMed
  91. Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S87-9 - PubMed

Publication Types